Non-Medical Cancer Treatment Methods

Non-Medical Cancer Treatment Methods.
When it comes to easing the secondary gear of certain breast cancer drugs, acupuncture may work no better than a "sham" version of the technique, a diminutive trial suggests. Breast cancer drugs known as aromatase inhibitors often cause side things such as muscle and joint pain, as well as hot flashes and other menopause-like symptoms homepage here. And in the new study, researchers found that women who received either really acupuncture or a sham variation saw a similar gain in those side effects over eight weeks.

And "That suggests that any benefit from the real acupuncture sessions resulted from a placebo effect," said Dr Patricia Ganz, a cancer connoisseur at the University of California, Los Angeles School of Medicine who was not labyrinthine in the study. The placebo effect, which is seen in care studies of all kinds, refers to the phenomenon where some people on an inactive "therapy" get better info. However, it's abstruse to know what to make of the current findings, in part because the study was so small who studies quality-of-life issues in cancer patients.

And "I just don't mark you can come to any conclusions. Practitioners of acupuncture interpolate thin needles into specific points in the body to bring about therapeutic effects such as pain relief. According to old Chinese medicine, acupuncture works by stimulating certain points on the overlay believed to affect the flow of energy, or "qi" (pronounced "chee"), through the body.

The study, published online Dec 23, 2013 in the memoir Cancer, included 47 women who were on aromatase inhibitors for early-stage titty cancer. Aromatase inhibitors include the drugs anastrozole (Arimidex), letrozole (Femara) and exemestane (Aromasin). They better lower the body's level of estrogen, which fuels tumor tumour in most women with breast cancer.

Half were randomly assigned to a weekly acupuncture conference for eight weeks; the other half had sham acupuncture sessions, which involved retractable needles. Overall, women in both groups reported an rehabilitation in certain drug side effects, such as claptrap flash severity. But there were no clear differences between the two groups. And in an earlier study, the researchers found the same decoration when they focused on the side effect of muscle and joint pain.

Development Of Tablets To Reduce The Desire For High-Calorie Food

Development Of Tablets To Reduce The Desire For High-Calorie Food.
You're dieting, and you identify you should linger away from high-calorie snacks. Yet, your eyes be preserved straying toward that box of chocolates, and you wish there was a pill to restrain your impulse to inhale them. Such a lozenge might one day be a real possibility, according to findings presented Tuesday at the Endocrine Society's annual tryst in San Diego dangers of trichozed. It would block the activity of ghrelin, the "hunger hormone" that stimulates the proclivity centers of the brain.

The study, reported by Dr Tony Goldstone, a consultant endocrinologist at the British Medical Research Council Clinical Sciences Center at Imperial College London, showed that ghrelin does assemble the passion for high-calorie foods in humans. "It's been known from animal and one work that ghrelin makes people hungrier bra size katrina. There has been a suspicion from animal work that it can also activate the rewards pathways of the brain and may be involved in the response to more rewarding foods, but we didn't have evidence of that in people".

The workroom that provided such evidence had 18 healthy adults look at pictures of different foods on three mornings, once after skipping breakfast and twice about 90 minutes after having breakfast. On one of the breakfast-eating mornings, all the participants got injections - some of zest water, some of ghrelin. Then they looked at pictures of high-calorie foods such as chocolate, piece and pizza, and low-calorie foods such as salads and vegetables.

The participants in use a keyboard to classify the appeal of those pictures. Low-calorie foods were rated about the same, no upset what was in the injections. But the high-calorie foods, especially sweets, rated higher in those who got ghrelin. "It seems to vary the desire for high-calorie foods more than low-calorie foods," Goldstone said of ghrelin.

In The USA Scientists Have Found The New Causes Of Glaucoma

In The USA Scientists Have Found The New Causes Of Glaucoma.
Glucosamine supplements that millions of Americans deduct to helper treat informed and knee osteoarthritis may have an unexpected side effect: They may increase risk for developing glaucoma, a unimportant new study of older adults suggests in May 2013. Glaucoma occurs when there is an development of intraocular pressure (IOP) or pressure inside the eye vimax. Left untreated, glaucoma is one of the peerless causes of blindness.

In the new study of 17 people, whose average age was 76 years, 11 participants had their discrimination pressure measured before, during and after taking glucosamine supplements. The other six had their knowledge pressure measured while and after they took the supplements keppra common side effects. Overall, pressure inside the visual acuity was higher when participants were taking glucosamine, but did return to normal after they stopped taking these supplements, the study showed.

So "This reading shows a reversible effect of these changes, which is reassuring," wrote researchers led by Dr Ryan Murphy at the University of New England College of Osteopathic Medicine in Biddeford, Maine. "However, the prospect that immutable damage can result from prolonged use of glucosamine supplementation is not eliminated. Monitoring IOP in patients choosing to postscript with glucosamine may be indicated".

Exactly how glucosamine supplements could affect make inside the eye is not fully understood, but several theories exist. For example, glucosamine is a herald for molecules called glycosaminoglycans, which may elevate eye pressure. The findings are published online May 23 as a examination letter in JAMA Ophthalmology.

High Levels Of Blood HDL Cholesterol Protects Against Heart Disease And Reduces The Risk Of Cancer

High Levels Of Blood HDL Cholesterol Protects Against Heart Disease And Reduces The Risk Of Cancer.
Higher blood levels of HDL cholesterol, the "good" gracious that protects against mettle disease, are also strongly associated with a tone down hazard of cancer, a new review of studies suggests. "For about a 10-point increase of HDL, there is a reduced danger of cancer by about one third over an average follow-up of 4,5 years," said Dr Richard Karas, supervisor director of the Tufts Medical Center Molecular Cardiology Research Institute and move author of a report in the June 22 issue of the Journal of the American College of Cardiology. Those numbers come from an opinion of 24 randomized controlled trials, aimed at determining the signification on heart disease of lowering levels of "bad" LDL cholesterol, through the use of statin drugs.

The reviewing singled out trials that also recorded the incidence of cancer among the participants. The researchers statement a 36 percent lower cancer rate for every 10 milligrams per liter (mg/dl) higher aim of HDL. But while the relationship between higher HDL and lower cancer imperil was independent of other cancer risk factors, such as smoking, obesity and age, Karas was thorough to say the study does not prove cause and effect.

So "We can say that higher levels of HDL are associated with a bring risk of cancer, but we can't say that one causes the other". Exactly so, said Dr Jennifer Robinson, professor of epidemiology and panacea at the University of Iowa College of Public Health, who wrote an accompanying editorial. High HDL levels may completely be a marker of the feather of good traits that reduce both cardiovascular and cancer risk.

July Effect For Stroke Patients

July Effect For Stroke Patients.
People who deteriorate strokes in July - the month when medical trainees inauguration their hospital work - don't cost any worse than stroke patients treated the rest of the year, a new study finds. Researchers investigating the designated "July effect" found that when recent medical school graduates begin their residency programs every summer in teaching hospitals, this modification doesn't reduce the quality of care for patients with pressing medical conditions, such as stroke. "We found there was no higher rate of deaths after 30 or 90 days, no poorer or greater rates of disablement or loss of independence and no evidence of a July effect for seizure patients," said the study's lead author, Dr Gustavo Saposnik, director of the Stroke Research Center of St Michael's Hospital, Toronto, in a asylum news release.

For the study, published recently in the Journal of Stroke and Cerebrovascular Diseases, the researchers examined records on more than 10300 patients who had an ischemic act (stroke caused by a blood clot) between July 2003 and March 2008. They also analyzed size of hospitalization, referrals to long-term custody facilities and be in want of for readmission or emergency room treatment for a stroke or any other reason in the month after their discharge.